Announcement on the Holding Subsidiary's Obtaining of the "Drug GMP Certificate"
Release time:
2021-05-20
Securities Code: 600668 Securities Abbreviation: Jianfeng Group Announcement No.: Pro 2019-034
Bond Abbreviation: 13 Peak 02 Bond Code: 122344
Zhejiang Jianfeng Group Co., Ltd.
Announcement
for the authenticity, accuracy and completeness of its contents.
Recently, Zhejiang Jianfeng Group Co., Ltd. (hereinafter referred to as "the company") holding subsidiary Zhejiang Jianfeng Pharmaceutical Co., Ltd. (hereinafter referred to as "Jianfeng Pharmaceutical")
received the "Drug GMP Certificate" issued by Zhejiang Food and Drug Administration. The relevant information is hereby announced as follows:
1. GMPCertification Related Information
Enterprise Name: Zhejiang Jianfeng Pharmaceutical Co., Ltd.Address: No. 58
Certificate No.: ZJ20190116
Certification Scope: powder injection (including cephalosporins) and freeze-dried powder injection
certification date: 2019
10 31
valid: 202410 30
2. GMPCertificate Involving Production Line
| Production Line Name |
Design Annual Capacity |
Main Variety |
| Powder Injection Production Line |
about 2000 |
cefmenoxime hydrochloride for injection, cefoxitin sodium for injection |
| freeze-dried powder injection production line |
about 1000 |
penciclovir for injection, for injection ribavirin |
| Drug Name |
Dosage Form |
Therapeutic Field |
Manufacturer |
| Injection Cefmenoxime Hydrochloride |
Powder Injection (Including Cephalosporins) |
Anti-infection |
Shanghai Shangyao Xinya Pharmaceutical Co., Ltd., Liaoning Haisco Pharmaceutical Co., Ltd., Hainan Tianhuang Pharmaceutical Co., Ltd., Hainan Lingkang Pharmaceutical Co., Ltd. and Jianfeng Pharmaceutical Co., Ltd. and other 10 . |
| Injection Cefoxitin Sodium |
Powder Injection (Including Cephalosporins) |
Anti-infection |
Harbin Pharmaceutical Group Pharmaceutical General Factory, Guangdong Bozhou Pharmaceutical Co., Ltd., Sichuan Pharmaceutical Preparation Co., Ltd., Shandong Luoxin Pharmaceutical Group Co., Ltd. and Jianfeng Pharmaceutical Co., etc. 49 home. |
| Penciclovir for Injection |
Freeze-dried Powder Injection |
Antivirus |
Ruiyang Pharmaceutical Co., Ltd. and Jianfeng Pharmaceutical . |
Ribavirin for Injection |
Freeze-dried Powder Injection |
Antivirus |
Shanghai Shangyao Xinya Pharmaceutical Co., Ltd., Zhejiang Asia Pacific Pharmaceutical Co., Ltd., Haikou Qili Pharmaceutical Co., Ltd., Hainan General Kangli Pharmaceutical Co., Ltd. and Jianfeng Pharmaceutical Co., Ltd. 209 7 . |
, "Major Manufacturers " information in the above table mainly comes from the website of china food and drug administration;
4. Impact on Listed Companies and Risk TipsThe "GMP
Certificate" obtained by Jianfeng Pharmaceutical Co., Ltd. this time is that its original GMP certificate for powder injection and freeze-dried powder injection production line expires and obtains the certificate after re-certification. Re-obtaining the GMP certificate will help ensure the production capacity of the above-mentioned products and ensure the continuity of market supply. It will not have a significant impact on the Company's current operations. The future sales of various drugs of
Company may be affected by the market environment, industry policies, supply and demand and other factors, with certain uncertainties. Please the majority of investors cautious decision-making, pay attention to prevent investment risk.hereby announce
Zhejiang Jianfeng Group Co., Ltd.
Board of Directors
November 6
, 2019
More information
In March, the authoritative organization of the cement industry successively released two series of lists of China's top 500 building materials enterprises in 2022 and China's top 100 cement clinker production capacity in 2022. Jianfeng Group ranked among the "top 100" in the two lists ". The list of China's top 500 building materials enterprises was officially released in early March. This series of lists was selected by the China Building Materials Enterprise Management Association. Through more than 20 years of comprehensive data research on China's building materials industry, referring to international practices, the rankings are based on the company's annual operating income., Cement products, building ceramics, waterproof materials, aluminum-plastic profiles, coatings, glass, building materials equipment manufacturing and other sub-industries related to building materials. Jianfeng Group ranks 96th among the companies on the list and 27th among the cement manufacturers on the list. On March 16, the awarding ceremony of 2022 China's top 100 cement clinker production capacity list was held in Hangzhou. This series of lists is released by China Cement Network, an authoritative organization in China's cement industry. The ranking is based on the total production capacity (excluding the production capacity of other kiln types and grinding stations) of new dry clinker production lines completed and put into operation by Chinese cement enterprises in China as of December 31, 2022. The data statistics are calculated based on the design production capacity and 310 days of annual operation. Jianfeng Group ranked 53rd with an annual design capacity of 3.627 million tons. (this newspaper reporter)
2023
03-21
Company sends off retired employees
On the morning of February 22, the trade union of the group company held a simple and warm farewell party for retired employees in 2021-2022. More than 50 retired employees gathered together to discuss and exchange with Jiang Xiaomeng and other group leaders.
2023
03-04
On the first day of the new year, group leaders went to the grassroots level.
On January 29, the first day of work after the Spring Festival holiday, the leaders of the group company made a video connection to subordinate enterprises stationed abroad, and separately visited the gold enterprises to learn about the resumption of work and put forward requirements for the implementation of the work plan for the new year.
2023
02-17
Group Companies Commend 2022 Advanced
On the morning of January 18, the group company held the 2022 annual summary commendation meeting to review the work of the previous year, make arrangements for the work in 2023, sign the 2023 economic responsibility system with various professional companies and directly affiliated enterprises, and solemnly commend the 2022 advanced collectives and individuals.
2023
01-29
Jiang Xiaomeng re-elected chairman of the Municipal Federation of Industry and Commerce
On December 24, 2022, the Jinhua Federation of Industry and Commerce (General Chamber of Commerce) held the seventh member representative meeting. Jiang Xiaomeng, secretary of the party committee and chairman of the group company, was re-elected as the chairman of the Municipal Federation of Industry and Commerce at this meeting.
2023
01-12
Peak Pharmaceutical Donates Epidemic Prevention Materials
Since the optimization and adjustment of the new crown infection epidemic management policy, there has been an explosive growth of infected people in the country, and the pressure on the supply of related materials has increased sharply. Before and after New Year's Day, the company has twice organized epidemic prevention materials, through the Jinhua City Charity Federation, Jinhua City Economic and Technological Development Zone Charity Federation targeted donations, a total value of more than 200,000 yuan.
2023
01-12